VIM and rheumatoid arthritis: Both intracellular proteins (for example, vimentin) and extracellular proteins (for example, fibrinogen) are targets for ACPAs in RA [21,22], and the citrullinated forms of vimentin and fibrinogen and fibrin have been shown to enhance a proinflammatory immune response in ACPA-positive patients [23–25].